Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in various diagnostic techniques. Diagnosis of malaria takes place by the utilization of a number of techniques such as rapid diagnostic tests (RDTs), molecular diagnostics, and by detecting parasites using microscopy.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1972
This research study has been compiled by conducting extensive market analysis and collecting inputs from leading industry experts. The study includes the market’s growth prospects in the forthcoming years. The study has been collated by using an objective combination of primary and secondary research. A number of market dynamics such as growth drivers, inhibitors, trends, and opportunities, with their respective effect on the growth of the market, are also presented in this research report.
The report employs the Porter’s five forces model, according to which the buyer’s bargaining power is high within this market owing to a number of suppliers making diagnostic kits. In the report, global initiatives taken for reducing the deaths caused by malaria have also been elaborated upon and the prime regions conducive for investment in the malaria diagnostics market have been evaluated on the basis of the future growth potential of the malaria diagnostic market.
Overview of the Malaria Diagnostics Market
Advanced malaria diagnostic tests have revolutionized malaria diagnosis and are highly demanded. These tests are used to detect the antigens of the malaria parasites. A number of diagnostic tests are utilized and amongst them, some are used to detect particular species of Plasmodium, while others are employed for the detection of multiple species.
The detection techniques for malaria include QBC technique, serological tests, and peripheral blood smears (PBS). A number of drugs are also utilized for the treatment of malaria, such as atovaquone-proguanil (Malarone), artemether-lumefantrine (Coartem), doxycycline (utilized in combination with quinine), chloroquine, clindamycin (utilized in combination with quinine), mefloquine (Lariam), quinine, and quinidine.
The increasing public awareness on malaria and the various technological developments are the prime factors stimulating the growth of the market for malaria diagnostics. On the other hand, the technological complications involved in current diagnostic tests may restrain the growth of the market in the coming years.
Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1972
On the basis of geography, the malaria diagnostics market is segmented into Asia Pacific, North America, Europe, and Rest of the World (RoW). Amongst these, Asia Pacific and Europe lead the market owing to the increasing prevalence of malaria and the rising awareness on the disease amongst people here in these regions. The high fatality rate due to malaria, particularly in the younger generation, is predicted to drive the malaria diagnostics market within the developing economies of RoW and Asia Pacific.
Key players in the Malaria Diagnostics Market
The prominent players dominant in the malaria diagnostics market include Abbott Laboratories, Beckman Coulter/Danaher, bioMerieux, Bio-Rad Laboratories, Inc., Bio-Rad, Life Technology, Novartis Diagnostics, Ortho-Clinical Diagnostics, Siemens Healthcare, and Wako Chemicals, Inc., among others.